Frieda Chan joined CoMotion in 2021, where she manages a portfolio with innovations in the fields of biological materials, therapeutics, and medicine. Prior to joining CoMotion, she worked as a Technology Manager at Fred Hutchison Cancer Research Center and a Patent Agent at Seed IP LLP and Cooley LLP. She has a PhD in Molecular Biosciences from Washington State University and completed a post-doctoral fellowship at Fred Hutchinson Cancer Research Center. She has extensive background in biochemistry, immunology, vaccines and infectious disease, cell and gene therapy, stem cell research, reproductive biology, and microbiology. Additionally, she is a professional musician with Bachelor, Master, and Doctorate degrees in flute performance.